OncoCyte
OCX
#9348
Rank
S$0.11 B
Marketcap
S$4.15
Share price
17.22%
Change (1 day)
34.70%
Change (1 year)

Revenue for OncoCyte (OCX)

Revenue in 2025 (TTM): S$5.18 Million

According to OncoCyte 's latest financial reports the company's current revenue (TTM ) is S$4.98 Million. In 2024 the company made a revenue of S$2.55 Million an increase over the revenue in the year 2023 that were of S$1.98 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for OncoCyte from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) S$5.18 M102.61%
2024 S$2.55 M28.8%
2023 S$1.98 M-151.66%
2022 -S$3.85 Million-136.78%
2021 S$10.44 M548.83%
2020 S$1.61 M
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA